Sloan Kettering Institute

Sloan Kettering Institute
Memorial Sloan Kettering · CC BY-SA 4.0 · source
Name	Sloan Kettering Institute
Established	1945
Type	Research Institute
Location	New York City, New York, United States
Parent	Memorial Sloan Kettering Cancer Center

Sloan Kettering Institute is a basic and translational biomedical research center focused on cancer biology, immunology, and therapeutic development. It conducts molecular, cellular, and systems-level studies that connect laboratory discoveries to clinical practice at Memorial Sloan Kettering Cancer Center, Rockefeller University, and the broader biomedical community. The institute's work intersects with Nobel Prize winners, Howard Hughes Medical Institute investigators, and leaders from universities and research hospitals worldwide.

History

Founded in the mid-20th century amid postwar biomedical expansion, the institute grew from philanthropic support by industrialist family foundations and private donors tied to New York philanthropy. Early faculty included investigators associated with Rockefeller University, Columbia University, New York University, and collaborators from Massachusetts Institute of Technology and Harvard University. Over successive decades the institute attracted scientists who had trained at Stanford University, University of California, San Francisco, Johns Hopkins University, University of Pennsylvania, Yale University, Princeton University, University of Chicago, Duke University, University of California, Berkeley, University of Cambridge, University of Oxford, McGill University, Karolinska Institutet, Max Planck Society, Institut Pasteur, Cold Spring Harbor Laboratory, and The Salk Institute.

The institute's trajectory has been shaped by major biomedical events and funding initiatives such as the postwar expansion of the National Institutes of Health, the molecular biology revolution sparked by work at California Institute of Technology and University of Geneva, and the biotechnology boom that linked academic labs to companies like Genentech, Amgen, Biogen, Pfizer, Merck, and Novartis. Prominent alumni moved to leadership roles at institutions such as Dana-Farber Cancer Institute, Fred Hutchinson Cancer Center, Baylor College of Medicine, Weill Cornell Medicine, Emory University, Mount Sinai Health System, Imperial College London, Monash University, and University of Toronto.

Research and Programs

Research programs emphasize cancer cell signaling, DNA damage and repair, chromatin biology, tumor immunology, and cancer metabolism, with teams drawing from investigators who trained at Cold Spring Harbor Laboratory, Scripps Research, Whitehead Institute, Broad Institute, European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Bell Labs, and Los Alamos National Laboratory. Programs bridge basic science with translational science, working with clinicians from Memorial Sloan Kettering Cancer Center, surgeons from NewYork-Presbyterian Hospital, oncologists from Cleveland Clinic, and pathologists from Mayo Clinic.

Major programmatic areas interact with initiatives supported by foundations such as the Gates Foundation, Simons Foundation, Howard Hughes Medical Institute, Ludwig Institute for Cancer Research, Susan G. Komen, American Cancer Society, Alfred P. Sloan Foundation, and Rockefeller Foundation. Faculty lead projects in single-cell genomics, computational biology, and structural biology, collaborating with teams at National Cancer Institute, European Commission, Human Genome Project veterans, and consortia like the Cancer Genome Atlas and the International Cancer Genome Consortium.

Facilities and Institutes

State-of-the-art core facilities include genomics, proteomics, cryo-electron microscopy, imaging, flow cytometry, and animal modeling centers, developed alongside infrastructure from New York-Presbyterian Hospital, Memorial Hospital, and regional biotech incubators such as JLABS affiliates and commercial partners like Illumina, Thermo Fisher Scientific, Agilent Technologies, Bruker, Zeiss, and Leica Microsystems. Structural biology work uses microscopes and software linked to projects from European Molecular Biology Laboratory groups and collaborations with Diamond Light Source and Brookhaven National Laboratory.

Translational platforms support early-phase studies with regulatory and clinical trial expertise drawn from networks including Food and Drug Administration, European Medicines Agency, National Comprehensive Cancer Network, and cooperative groups like Alliance for Clinical Trials in Oncology and Eastern Cooperative Oncology Group.

Education and Training

The institute runs postdoctoral, doctoral, and residency training programs that integrate with graduate programs at Weill Cornell Graduate School of Medical Sciences, Rockefeller University Graduate Program, and partnerships with Columbia University Vagelos College of Physicians and Surgeons and NYU Grossman School of Medicine. Trainees frequently rotate through laboratories associated with Howard Hughes Medical Institute investigators, attend courses influenced by curricula from Cold Spring Harbor Laboratory and EMBO, and participate in workshops sponsored by the American Association for Cancer Research and the American Society of Clinical Oncology.

Career development pathways have propelled trainees to appointments at institutions including University of California, San Diego, Northwestern University, University of Michigan, University of Washington, Vanderbilt University, University of North Carolina at Chapel Hill, and international centers such as Peking University, Seoul National University, University of Melbourne, and University of Copenhagen.

Leadership and Organization

Institutional leadership draws from executives and scientists with prior roles at Memorial Sloan Kettering Cancer Center, Rockefeller University, Columbia University, Harvard Medical School, Yale School of Medicine, and Johns Hopkins Medicine. The organizational model integrates basic research directors, translational program leaders, and administrative executives who interact with trustees and donors connected to New York City cultural and philanthropic institutions such as The Rockefeller Foundation and corporate partners including Johnson & Johnson and Roche. Governance aligns with clinical leadership at affiliated hospitals like Lenox Hill Hospital and networks involving Mount Sinai Beth Israel.

Collaborations and Partnerships

The institute maintains collaborations with international research centers and biotech and pharmaceutical partners, including translational alliances with Genentech, Roche, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Takeda, GlaxoSmithKline, and startups spun out to incubators such as Start-Up NY and university tech transfer offices at Columbia Technology Ventures and Weill Cornell Medicine's Office of Technology Transfer. Academic partnerships include cooperative research with Rockefeller University, Weill Cornell Medicine, Columbia University Irving Medical Center, New York University Langone Health, and consortia involving National Institutes of Health programs and international agencies like European Research Council.

Global research networks link the institute to clinical trial sites and centers of excellence at Royal Marsden, Institut Gustave Roussy, Peter MacCallum Cancer Centre, Fudan University Shanghai Cancer Center, and National University Hospital Singapore, supporting multicenter studies and translational pipelines.

Category:Cancer research institutes